NCT02263274

Brief Summary

The primary study objective is to measure the electrical fields evoked by tDCS using subjects who have implanted intracranial electrodes as part of their evaluation for epilepsy surgery. The measurements obtained in these subjects and their brain MRI will be employed to validate existing mathematical models. In the future, these refined models can be used to target tDCS to predetermined brain regions in healthy and subjects and patient populations. As described above in the safety section, the intensities of stimulation applied in this project are not expected to produce changes in brain function, are below intensities commonly applied in clinical trials, and fall well below safety limits suggested by animal studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

October 8, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 13, 2014

Completed
11.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 9, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 9, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

12.2 years

First QC Date

October 8, 2014

Last Update Submit

February 24, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Current Intensity

    MRI

    24 hour Post Op

  • Total charge (stimulation intensity x duration of stimulation in coulombs

    MRI

    24 Hour Post Op

  • Total electrode charge density (total charge/electrode area in coloumbs/meters2) as measured at various subdural and depth electrode recording sites

    MRI

    24 Hour Post Op

Study Arms (1)

Direct Cortical Measurement

EXPERIMENTAL

Consented subjects will also have transcranial electrodes applied at four extracranial sites, below the sterile dressing and distant from the surgical skull defect. The four electrodes will be placed in uniform positions based on the standard 10-10 electrode system, at the temples bilaterally (positions F9 and F10) and at the occiput bilaterally (positions PO9 and PO10). Subjects will be stimulated according to a predetermined set of parameters which fall well within empirically and computationally determined safety thresholds, as discussed above. The entire stimulation protocol is described in detail in section 5, and is anticipated to last no longer than 30 minutes.

Device: Transcranial Direct Current Stimulation (TDCS)

Interventions

Conventional tDCS and low-frequency tACS are commonly administered at a current intensity of 2 mA or less

Also known as: TDCS
Direct Cortical Measurement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Placement of intracranial electrode arrays (grid, strip and or depth electrodes) for seizure focus localization and/or mapping of eloquent cortex
  • Able to provide written informed consent
  • English-speaking patients only

You may not qualify if:

  • Cognitive impairment (Intelligence Quotient \<70)
  • Facial or forehead skin breakdown that would interfere with surface electrode placement
  • Contraindication to MRI
  • Known adhesive allergy
  • Space occupying intracranial pathology including brain tumor, ateriovenous malformation, cavernous malformation, prior surgical resection or significant encephalomalcia that would create unknown tissue inhomogeneity that cannot be accurately modeled.
  • Subjects who have had an electrographic or clinical seizure within one hour prior to the stimulation procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neurology

New York, New York, 11106, United States

Location

MeSH Terms

Conditions

Epilepsy

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Anli Liu, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2014

First Posted

October 13, 2014

Study Start

November 1, 2013

Primary Completion

January 9, 2026

Study Completion

January 9, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Locations